ORIGINAt the Hubrecht Institute a nonsense mutation at amino acid position 59 (Glu to stop) within the catalytic center ABC transporter-like domain of the rat Abcg2 (Bcrp) gene was isolated which eliminates all wild-type protein. Transferred to Charles River under exclusive license from Transposagen in 2010.
STRAIN CODE496 (HOMOZYGOUS)497 (HETEROZYGOUS)498 (WILD-TYPE)
COAT COLORWhite (albino)
MODEL INFORMATIONThe Abcg2 (Bcrp) TGEM® Rat Model harbors a premature stop codon (nonsense mutation at amino acid position E59 in the ABC transporter-like domain). Due to the rat’s close physiological similarities to humans, this model will improve in vivo ADME-tox and pharmacokinetics studies. The in vivo drug transport studies that are conducted in the Abcg2 (Bcrp) TGEM® Rat Model will enhance the ability to predict how drug candidates will perform in humans. These studies are critical for therapeutic development and usually required by the FDA for approval to conduct human clinical trials.
Abcg2 (Bcrp) is known to regulate the bioavailability of the following substances:
The expression of Abcg2 (Bcrp) tightly regulates the fate and function of subpopulations (SP) of cells with stem or progenitor properties in various tissues, including cardiac, tumor initiating cells (cancer stem cells), hematopoietic stem cells, bone marrow, gonad, lung, skeletal muscle and retinal cells(1). Therefore, the Abcg2 (Bcrp) TGEM® Rat Model may be useful for in vivo stem cell therapeutic studies. The model also provides a great assay to determine stem cell replacement therapy pro-proliferative or pro-differentiation properties, especially during tissue injury when proliferation is necessary. Testing new therapies such as stem cells in rat models has advantages for drug development and regulatory approval. Therefore, the Abcg2 (Bcrp) TGEM® Rat Model is suitable as an ideal tool for stem cell therapy development.
Humans and animal models with low or deficient Abcg2 (Bcrp) expression develop extreme sensitivity to dietary chlorophyll-breakdown product phenophorbide-a, resulting in phototoxic lesions on light exposed skin. The Abcg2 (Bcrp) TGEM® Rat Model may be a useful model for studying protoporphyria and diet-induced phototoxicity(2).
The Abcg2 (Bcrp) TGEM® Rat Model is deficient for a regulator of hypoxia. Abcg2 (Bcrp) binds and transports heme. In hematopoietic cells, Abcg2 (Bcrp) regulates sensitivity to heme accumulation and hypoxia, which can lead to mitrochondrial failure and cell death. Abcg2 (Bcrp) is upregulated during hypoxia, reduces heme accumulation to reduce hypoxic demand(3).
References 1) Pfister et al. (2008) Circ. Res. 103 (8): 825-35 2) Jonker et al. (2002) PNAS. 99 (24): 15649-54 3) Krishnamurthy et al. (2004) J. Biol. Chem. 279: 24218-225
RESEARCH APPLICATIONADME, drug transport, toxicology, pharmacokinetics, bioavailability, blood-brain barrier transport, stem cells, progenitor cells, proliferation, differentiation, tumor initiating cells, phototoxicity, protoporphyria, hypoxia
ORDERING INFORMATIONPlease call 1.800.LAB.RATS if you would like to place an order.
For additional information about the Bcrp TGEM® rats, please contact us at 1.877.CRIVER.1 or firstname.lastname@example.org.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
Our study, presented at the 2013 Experimental Biology Conference, focuses on the phenotype and genotype comparison for C57BL/6N substrains contributing to the International Mouse Phenotyping Consortium (IMPC).
Clinical pathology data can assist you in selecting the most appropriate model for your study and can provide important information on the physiology and health of your research animals.
Jun 21–Jun 25
This five-day meeting draws diverse professionals from around the world to share their breakthroughs in the prevention, diagnosis and treatment of diabetes.
Jun 28–Jun 28
Charles River offers a wide range of seminars, workshops and training courses for animal technicians, veterinarians, biologists and laboratory technicians who work with laboratory animals. For more information about our course on animal health monitoring, click "view more" below.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.